A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy

被引:94
作者
Zhang, Xinli [1 ]
Chen, Chen [1 ]
机构
[1] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Diabetic cardiomyopathy; Cardiac dysfunction; Impaired calcium handling; Oxidative stress; Fatty acid; Ion channel; Diagnosis; Treatment; ENDOTHELIAL GROWTH-FACTOR; VENTRICULAR DIASTOLIC DYSFUNCTION; SARCOPLASMIC-RETICULUM FUNCTION; ANGIOTENSIN-CONVERTING ENZYME; REDUCED CARDIAC EFFICIENCY; ACTION-POTENTIAL DURATION; MITOCHONDRIAL DYSFUNCTION; CONTRACTILE DYSFUNCTION; HEART-FAILURE; CARDIOVASCULAR-DISEASE;
D O I
10.1007/s12020-012-9623-1
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Diabetes mellitus is one of the most common chronic diseases across the world. Cardiovascular complication is the major morbidity and mortality among the diabetic patients. Diabetic cardiomyopathy, a new entity independent of coronary artery disease or hypertension, has been increasingly recognized by clinicians and epidemiologists. Cardiac dysfunction is the major characteristic of diabetic cardiomyopathy. For a better understanding of diabetic cardiomyopathy and necessary treatment strategy, several pathological mechanisms such as impaired calcium handling and increased oxidative stress, have been proposed through clinical and experimental observations. In this review, we will discuss the development of cardiac dysfunction, the mechanisms underlying diabetic cardiomyopathy, diagnostic methods, and treatment options.
引用
收藏
页码:398 / 409
页数:12
相关论文
共 135 条
[1]
Cardiac remodeling in obesity [J].
Abel, E. Dale ;
Litwin, Sheldon E. ;
Sweeney, Gary .
PHYSIOLOGICAL REVIEWS, 2008, 88 (02) :389-419
[2]
Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review [J].
Adeghate, E .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 261 (1-2) :187-191
[3]
PRECLINICAL ABNORMALITY OF LEFT-VENTRICULAR FUNCTION IN DIABETES-MELLITUS [J].
AHMED, SS ;
JAFERI, GA ;
NARANG, RM ;
REGAN, TJ .
AMERICAN HEART JOURNAL, 1975, 89 (02) :153-158
[4]
AUGMENTATION OF ATRIAL CONTRIBUTION TO LEFT-VENTRICULAR FILLING IN IDDM SUBJECTS AS ASSESSED BY DOPPLER ECHOCARDIOGRAPHY [J].
AIRAKSINEN, KEJ ;
KOISTINEN, MJ ;
IKAHEIMO, MJ ;
HUIKURI, HV ;
KORHONEN, U ;
PIRTTIAHO, H ;
LINNALUOTO, MK ;
TAKKUNEN, JT .
DIABETES CARE, 1989, 12 (02) :159-161
[5]
Serum heart type fatty acid binding protein levels in metabolic syndrome [J].
Akbal, Erdem ;
Ozbek, Mustafa ;
Gunes, Fahri ;
Akyurek, Omer ;
Ureten, Kemal ;
Delibasi, Tuncay .
ENDOCRINE, 2009, 36 (03) :433-437
[6]
Non-invasive magnetic resonance imaging assessment of myocardial changes and the effects of angiotensin-converting enzyme inhibition in diabetic rats [J].
Al-Shafei, AIM ;
Wise, RG ;
Gresham, GA ;
Bronns, G ;
Carpenter, TA ;
Hall, LD ;
Huang, CLH .
JOURNAL OF PHYSIOLOGY-LONDON, 2002, 538 (02) :541-553
[7]
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy [J].
An, Ding ;
Rodrigues, Brian .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 291 (04) :H1489-H1506
[8]
Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease [J].
Andersson, Charlotte ;
Gislason, Gunnar H. ;
Weeke, Peter ;
Hoffmann, Soren ;
Hansen, Peter R. ;
Torp-Pedersen, Christian ;
Sogaard, Peter .
CARDIOVASCULAR DIABETOLOGY, 2010, 9
[9]
Mitochondrial metabolism of reactive oxygen species [J].
Andreyev, AI ;
Kushnareva, YE ;
Starkov, AA .
BIOCHEMISTRY-MOSCOW, 2005, 70 (02) :200-214
[10]
Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) [J].
Aoyama, T ;
Peters, JM ;
Iritani, N ;
Nakajima, T ;
Furihata, K ;
Hashimoto, T ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5678-5684